Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00030576
Status:
COMPLETED
Last Update Posted:
2018-10-10
First Post:
2002-02-14
Brief Title:
Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Sponsor:
University Health Network Toronto
Organization:
University Health Network Toronto
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Cancer |
Keywords:
| Name | View |
|---|---|
| recurrent squamous cell carcinoma of sinus and nasal cavity | View |
| recurrent metastatic squamous neck cancer occult primary | View |
| neck cancer with occult primary squamous carcinoma | View |
| stage IV squamous cell carcinoma of the lip and oral cavity | View |
| recurrent squamous cell carcinoma of the lip and oral cavity | View |
| stage IV squamous cell carcinoma of the oropharynx | View |
| recurrent squamous cell carcinoma of the oropharynx | View |
| stage IV squamous cell carcinoma of the nasopharynx | View |
| recurrent squamous cell carcinoma of the nasopharynx | View |
| stage IV squamous cell carcinoma of the hypopharynx | View |
| recurrent squamous cell carcinoma of the hypopharynx | View |
| stage IV squamous cell carcinoma of the larynx | View |
| recurrent squamous cell carcinoma of the larynx | View |
| squamous cell carcinoma of paranasal sinus and nasal cavity | View |